nafronyl has been researched along with Peripheral Nervous System Diseases in 1 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Peripheral Nervous System Diseases: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meininger, V | 1 |
| Chaineau, E | 1 |
| Soudière, B | 1 |
1 other study available for nafronyl and Peripheral Nervous System Diseases
| Article | Year |
|---|---|
[Effect of naftidrofuryl (LS129) on axonal growth].
Topics: Animals; Axons; Cells, Cultured; Embryo, Mammalian; Humans; Mice; Microtubules; Nafronyl; Nerve Rege | 1994 |